Cargando…
Corrigendum to “Protective Effects of Simvastatin, a Lipid Lowering Agent, Against Oxidative Damage in Experimental Diabetic Rats”
Autores principales: | Mohamadin, Ahmed M., Elberry, Ahmed A., Abdel Gawad, Hala S., Morsy, Gehan M., Al-Abbasi, Fahad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769670/ https://www.ncbi.nlm.nih.gov/pubmed/33414967 http://dx.doi.org/10.1155/2020/4536827 |
Ejemplares similares
-
Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic Rats
por: Mohamadin, Ahmed M., et al.
Publicado: (2011) -
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022) -
Corrigendum to “T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage”
por: Liappas, Georgios, et al.
Publicado: (2017) -
Corrigendum to “Reduced Oxidative Stress Contributes to the Lipid Lowering Effects of Isoquercitrin in Free Fatty Acids Induced Hepatocytes”
por: Hassan, Waseem, et al.
Publicado: (2015) -
Corrigendum to “High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI”
por: Ahmed, Sheikh Sohail, et al.
Publicado: (2015)